Immune Therapeutics, Inc. 5/A
5/A · Immune Therapeutics, Inc. · Filed Apr 5, 2016
Insider Transaction Report
Form 5/AAmended
Griffin Noreen
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
COMMON STOCK
2015-12-04$80000.00/sh−1,000,000$80,000,000,000→ 4,317,710 total
Footnotes (2)
- [F1]This transaction was reported on the Form 5 filed on March 30, 2016 but incorrectly identified the price as $50,000 rather than the correct price of $80,000 for 1 million shares ($0.08 per share).
- [F2]This form amends the transaction dated 12/4/15 reported on the Form 5 filed on March 30, 2016.